Stocks have been swinging up and down for several days now, but the major indices were indicated to open up on Thursday. The bull market may now be over nine years old, but it has become more obvious that the trend of buying pullbacks is now much more vulnerable to sellers, volatility and each major news headline. This makes it more difficult for investors to decide how they want their assets positioned for the rest of 2018 and beyond.

24/7 Wall St. reviews dozens of analyst research reports each day of the week. Our goal is to find new ideas for investors and traders alike. Some analyst reports cover stocks to buy and some cover stocks to sell or to avoid.

Additional color and commentary has been added on most of the daily analyst reports. The consensus analyst price targets and other valuation metrics are from the Thomson Reuters sell-side research service.

These were the top analyst upgrades, downgrades and other research calls from Thursday, April 12, 2018.

Albemarle Corp. (NYSE: ALB) was maintained as Overweight but the price target was cut to $140 from $148 (versus a $93.31 prior close) at KeyBanc Capital Markets.

American Airlines Group Inc. (NASDAQ: AAL) was maintained as Overweight but the price target was cut to $55 from $61 at Morgan Stanley. This was after a 4.3% drop to $45.40 on Wednesday, and the stock has a 52-week range of $42.01 to $59.08. It also had a consensus target price of $63.90.

Avangrid Inc. (NYSE: AGR) was reiterated as Buy with a $54 price objective (versus a $50.50 close) at Merrill Lynch.

Bed Bath & Beyond (NASDAQ: BBBY) was maintained as Underweight and the price target was cut to $16 from $17 at KeyBanc Capital Markets. Wedbush maintained its Neutral rating and it has a $21.50 price target while noting severe margin pressure. Merrill Lynch reiterated its Underperform rating but lowered its price objective to $16. Credit Suisse maintained its Neutral rating but lowered its target to $20 from $25.

Bellicum Pharmaceuticals Inc. (NASDAQ: BLCM) was raised to Outperform from Market Perform at Wells Fargo. Shares were up 1.5% at $6.85 on Wednesday but were up 21% at $8.30 on Thursday after news that a clinical hold was lifted on studies of its BX-501 in the effort that may enable physicians to more safely perform stem cell transplants.

Delta Air Lines Inc. (NYSE: DAL) was maintained as Overweight but the price target was cut to $65 from $66 at Morgan Stanley. This was after a 1.7% drop to $51.47 on Wednesday. Delta’s consensus target price was $73.00.

Ellie Mae Inc. (NYSE: ELLI) was downgraded to Underperform from Neutral and the price target was cut to $69 from $90 at Wedbush, with the firm noting that there are difficulties ahead with a disappointing year for mortgage originations in 2018 and with skepticism around Ellie Mae’s ability to achieve its long-term growth and profitability targets. Its shares were down 1% at $94.00 on Wednesday and were indicated down 2.6% at $91.50 on Thursday.

Follow @Jonogg on Twitter to receive the daily analyst calls and other market research calls directly on your feed.
Fastenal Co. (NASDAQ: FAST) was reiterated as Buy with a $62 price target at Argus, with the independent research firm noting that the recent weakness offers a buying opportunity, along with a dividend hike and confident outlook.

FMC Corp. (NYSE: FMC) was raised to Outperform from Market Perform at BMO Capital Markets.

Hershey Co. (NYSE: HSY) was started as Neutral with a $99 price target at Piper Jaffray.

J.B. Hunt Transport Services Inc. (NASDAQ: JBHT) was downgraded to Sector Weight from Overweight at KeyBanc Capital Markets.

Johnson & Johnson (NYSE: JNJ) was reiterated as Outperform with a $154 price target at Credit Suisse. The firm remains bullish despite weakness since the last earnings report and 2018 guidance. It also sees further room for upside.

Leap Therapeutics Inc. (NASDAQ: LPTX) was up 1.7% at $9.71 on Wednesday and was up 3.5% at $10.05 on Thursday. H.C. Wainwright started it as Buy and assigned a $12.50 target price.

Mallinckrodt PLC (NYSE: MNK) was started with a Hold rating at SunTrust Robinson Humphrey.

MDC Partners Inc. (NASDAQ: MDCA) was raised to Outperform from Market Perform at Wells Fargo.

Mylan N.V. (NASDAQ: MYL) was raised to Outperform from Market Perform at Leerink. The stock closed down 2.7% at $40.39 on Wednesday and was indicated up 1% at $40.80 on Thursday. The 52-week range is $29.39 to $47.82, and the consensus target price is $49.95.

NetApp Inc. (NASDAQ: NTAP) was reiterated as Buy and the price target was raised to $76 from $66 (versus a $66.14 close) at Argus. The firm noted that NetApp is being aggressive in its own operating and capital goals with a more cost-efficient structure while delivering higher growth and returns to shareholders. Shares closed at $66.14 on Wednesday and were indicated up 1.5% at $67.10, with a 52-week range of $37.43 to $66.79 and a consensus target price of $69.36.

PNM Resources Inc. (NYSE: PNM) was raised to In-Line from Underperform at Evercore ISI. It closed at $37.50 and has a 52-week range of $33.75 to $46.00.

Prologis Inc. (NYSE: PLD) was raised to Buy from Hold at Jefferies. Shares closed at $61.62 and have a 52-week range of $52.98 to $67.53.

Puma Biotechnology Inc. (NASDAQ: PBYI) was downgraded to Equal Weight from Overweight at Barclays.

Southwest Airlines Co. (NYSE: LUV) was maintained as Overweight but the price target was cut to $69 from $72 at Morgan Stanley. Its shares closed down almost 1.2% at $53.50 on Wednesday, in a 52-week range of $49.76 to $66.99. Southwest had a consensus target price of $72.37.

Check out the six most shorted NYSE stocks and the six most shorted Nasdaq stocks.

Wednesday’s top analyst calls were in shares of Agilent, Alphabet, Amazon, Apple, Citigroup, Facebook, JPMorgan, Mattel, Netflix and many more.

Get Our Free Investment Newsletter

I have read, and agree to the Terms of Use

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.